- Home
- CRNC vs SLP Comparison
CRNC vs SLP Comparison
Compare CRNC & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNC | SLP |
|---|---|---|
| Founded | 2020 | 1996 |
| Country | United States | United States |
| Employees | 1300 | N/A |
| Industry | EDP Services | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.6M | 371.9M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CRNC | SLP |
|---|---|---|
| Price | $7.98 | $18.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $10.25 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 541.2K | 148.8K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.95 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $251,781,000.00 | $59,577,000.00 |
| Revenue This Year | $27.18 | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ N/A | $42.81 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $5.85 | $11.09 |
| 52 Week High | $13.74 | $21.01 |
Technical Indicators
Market Signals| Indicator | CRNC | SLP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 57.51 |
| Support Level | N/A | $18.22 |
| Resistance Level | N/A | $18.46 |
| Average True Range (ATR) | 0.00 | 0.02 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 33.33 |
Price Performance
Historical ComparisonAbout CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.